Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-24-131663·CVI Investments, Inc.
Schedule 13G ownership disclosure
PHIO PHARMACEUTICALS CORP
Common Stock, par value $0.0001 per share · CUSIP: 71880W501
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 109,298.00 · Class: 7.3%
- Heights Capital Management, Inc.
Shares: 109,298.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-131663
- Form type
- SCHEDULE 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Dec 26, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13G beneficial ownership